Francesco Errani

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Capillary Electrophoresis

Protein Protein

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

František Zálešák, Francesco Nai, Marcin Herok, Elena Bochenkova, Rajiv Kumar Bedi, Yaozong Li, Francesco Errani, Amedeo Caflisch
Structure-Based Design of a Potent and Selective YTHDC1 Ligand. Journal of medicinal chemistry 67 (11) (2024)
František Zálešák, Francesco Nai, Marcin Herok, Elena Bochenkova, Rajiv Kumar Bedi, Yaozong Li, Francesco Errani, Amedeo Caflisch
Structure-Based Design of a Potent and Selective YTHDC1 Ligand. Journal of medicinal chemistry (2024)
František Zálešák, Francesco Nai, Marcin Herok, Elena Bochenkova, Rajiv Kumar Bedi, Yaozong Li, Francesco Errani, Amedeo Caflisch
Structure-Based Design of a Potent and Selective YTHDC1 Ligand. Journal of medicinal chemistry 67 (11) (2024)
František Zálešák, Francesco Nai, Marcin Herok, Elena Bochenkova, Rajiv Kumar Bedi, Yaozong Li, Francesco Errani, Amedeo Caflisch
Structure-Based Design of a Potent and Selective YTHDC1 Ligand. Journal of medicinal chemistry 67 (11) (2024)
Francesco Errani, Annalisa Invernizzi, Marcin Herok, Elena Bochenkova, Fiona Stamm, Ivan Corbeski, Valeria Romanucci, Giovanni Di Fabio, František Zálešák, Amedeo Caflisch
Proteolysis Targeting Chimera Degraders of the METTL3-14 m 6 A-RNA Methyltransferase. JACS Au 4 (2) (2024)
Francesco Errani, Annalisa Invernizzi, Marcin Herok, Elena Bochenkova, Fiona Stamm, Ivan Corbeski, Valeria Romanucci, Giovanni Di Fabio, František Zálešák, Amedeo Caflisch
Proteolysis Targeting Chimera Degraders of the METTL3-14 m 6 A-RNA Methyltransferase. JACS Au 4 (2) (2024)